The potential for the use of cell proliferation and oncogene expression as intermediate markers during liver carcinogenesis.
Intense research using animal models has indicated that chemically-induced rat liver cancer proceeds through multiple, distinct stages that can be characterised morphologically and biochemically. Primary human liver cancer, with hepatitis B and other environmental factors such as poor nutrition and food contaminating mycotoxins as contributing etiological factors, is one of the major causes of cancer deaths in African, Asian and some Western countries. Recent advances in surgical and diagnostic techniques have also allowed the identification of potential morphological precursors of primary human liver cancer, and suggested a model consistent with the concepts of initiation--promotion--progression as in the rat. The expression of proliferating cell nuclear antigen (PCNA), silver-staining nucleolar organiser regions (AgNOR), oncogenes and the tumor suppressor gene p53 in preneoplastic and neoplastic lesions of rat and human livers is presently reviewed. This undertaking is an attempt to evaluate whether the current knowledge regarding molecular mechanisms of carcinogenesis is sufficient to permit the use of these molecular parameters as 'intermediate' markers in studies of risk assessment and cancer prevention, without having to resort to tumor appearance as an end-point.
Mehta
R
R
Toxicology Research Division, Health Protection Branch, Health Canada, Ottawa, Ontario.
D000818:Animals; D014408:Biomarkers, Tumor; D006528:Carcinoma, Hepatocellular / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D002455:Cell Division; D002471:Cell Transformation, Neoplastic; D004195:Disease Models, Animal; D018450:Disease Progression; D016158:Genes, p53; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D009697:Nucleolus Organizer Region / Q000473:pathology; D011230:Precancerous Conditions / Q000235:genetics / Q000276:immunology / Q000473:pathology; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen / Q000096:biosynthesis; D011519:Proto-Oncogenes; D051381:Rats; D018570:Risk Assessment; D015398:Signal Transduction; D016622:Silver Staining
D014408:Biomarkers, Tumor; D018809:Proliferating Cell Nuclear Antigen